{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:29:25Z","timestamp":1791098965936,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00415-009-0062-8","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T11:52:43Z","timestamp":1232625163000},"page":"1872-1880","source":"Crossref","is-referenced-by-count":101,"title":["Weight loss in neurodegenerative disorders"],"prefix":"10.1007","volume":"255","author":[{"given":"N. A.","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"van der Marck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G. M.","family":"Olde Rikkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A. C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,22]]},"reference":[{"key":"62_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/oxfordjournals.aje.a116102","volume":"134","author":"Evans","year":"1991","unstructured":"Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE (1991) Risk of death from Alzheimer\u2019s disease in a community population of older persons. Am J Epidemiol 134(4):403\u2013412","journal-title":"Am J Epidemiol"},{"key":"62_CR2","first-page":"107","volume":"2","author":"Guyonnet","year":"1998","unstructured":"Guyonnet S, Nourhashemi F, Ousset PJ, Micas M, Ghisolfi A, Vellas B, et al. (1998) Factors associated with weight loss in Alzheimer\u2019s disease. J Nutr Health Aging 2(2):107\u2013109","journal-title":"J Nutr Health Aging"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurobiolaging.2005.08.021","volume":"26","author":"Craft","year":"2005","unstructured":"Craft S (2005) Insulin resistance syndrome and Alzheimer\u2019s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26(Suppl 1):65\u201369","journal-title":"Neurobiol Aging"},{"key":"62_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","volume":"3","author":"Craft","year":"2004","unstructured":"Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3(3):169\u2013178","journal-title":"Lancet Neurol"},{"key":"62_CR5","first-page":"38","volume":"11","author":"Gillette","year":"2007","unstructured":"Gillette GS, Abellan VK, Alix E, Andrieu S, Belmin J, Berrut G, et al. (2007) IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer\u2019s disease. J Nutr Health Aging 11(1):38\u201348","journal-title":"J Nutr Health Aging"},{"key":"62_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1300\/J052v26n03_02","volume":"26","author":"Tamura","year":"2007","unstructured":"Tamura BK, Masaki KH, Blanchette P (2007) Weight loss in patients with Alzheimer\u2019s disease. J Nutr Elder 26 (3\u20134):21\u201338","journal-title":"J Nutr Elder"},{"key":"62_CR7","doi-asserted-by":"crossref","first-page":"637S","DOI":"10.1093\/ajcn\/71.2.637s","volume":"71","author":"Gillette-Guyonnet","year":"2000","unstructured":"Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de G, I, Ousset PJ, Riviere D, et al. (2000) Weight loss in Alzheimer disease. Am J Clin Nutr 71(2): 637S\u2013642S","journal-title":"Am J Clin Nutr"},{"key":"62_CR8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","volume":"65","author":"Buchman","year":"2005","unstructured":"Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65(6):892\u2013897","journal-title":"Neurology"},{"key":"62_CR9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","volume":"330","author":"Whitmer","year":"2005","unstructured":"Whitmer RA, Gunderson EP, Barrett- Connor E, Quesenberry CP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330(7504):1360","journal-title":"BMJ"},{"key":"62_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archneur.64.3.392","volume":"64","author":"Luchsinger","year":"2007","unstructured":"Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64(3):392\u2013398","journal-title":"Arch Neurol"},{"key":"62_CR12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMcp043908","volume":"353","author":"Nutt","year":"2005","unstructured":"Nutt JG, Wooten GF (2005) Clinical practice. Diagnosis and initial management of Parkinson\u2019s disease. N Engl J Med 353(10):1021\u20131027","journal-title":"N Engl J Med"},{"key":"62_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5(3):235\u2013245","journal-title":"Lancet Neurol"},{"key":"62_CR14","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/mds.21068","volume":"21","author":"Bachmann","year":"2006","unstructured":"Bachmann CG, Trenkwalder C (2006) Body weight in patients with Parkinson\u2019s disease. Mov Disord 21(11):1824\u20131830","journal-title":"Mov Disord"},{"key":"62_CR15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","volume":"53","author":"Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson\u2019s disease. Ann Neurol 53(5):676\u2013679","journal-title":"Ann Neurol"},{"key":"62_CR16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.59.7.1051","volume":"59","author":"Abbott","year":"2002","unstructured":"Abbott RD, Ross GW, White LR, Nelson JS, Masaki KH, Tanner CM, et al. (2002) Midlife adiposity and the future risk of Parkinson\u2019s disease. Neurology 59(7):1051\u20131057","journal-title":"Neurology"},{"key":"62_CR17","unstructured":"Bates G, Harper PS, Jones L (2002) Huntington\u2019s Disease. Third edition. Oxford University Press"},{"key":"62_CR18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archneur.1992.00530280029014","volume":"49","author":"Kremer","year":"1992","unstructured":"Kremer HP, Roos RA (1992) Weight loss in Huntington\u2019s disease. Arch Neurol 49(4):349","journal-title":"Arch Neurol"},{"key":"62_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ajcn\/50.1.145","volume":"50","author":"Morales","year":"1989","unstructured":"Morales LM, Estevez J, Suarez H, Villalobos R, Chacin DB, Bonilla E (1989) Nutritional evaluation of Huntington disease patients. Am J Clin Nutr 50(1):145\u2013150","journal-title":"Am J Clin Nutr"},{"key":"62_CR20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","volume":"59","author":"Djousse","year":"2002","unstructured":"Djousse L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH (2002) Weight loss in early stage of Huntington\u2019s disease. Neurology 59(9):1325\u20131330","journal-title":"Neurology"},{"key":"62_CR21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.nut.2004.12.012","volume":"21","author":"Trejo","year":"2005","unstructured":"Trejo A, Boll MC, Alonso ME, Ochoa A, Velasquez L (2005) Use of oral nutritional supplements in patients with Huntington\u2019s disease. Nutrition 21(9):889\u2013894","journal-title":"Nutrition"},{"key":"62_CR22","unstructured":"Kremer HP (1992) The lateral hypothalamus in Huntington\u2019s, Alzheimer\u2019s and Parkinson\u2019s disease. Leiden, The Netherlands (Thesis)"},{"key":"62_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajpa.1330670304","volume":"67","author":"Farrer","year":"1985","unstructured":"Farrer LA, Meaney FJ (1985) An anthropometric assessment of Huntington\u2019s disease patients and families. Am J Phys Anthropol 67(3):185\u2013194","journal-title":"Am J Phys Anthropol"},{"key":"62_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.1320210213","volume":"21","author":"Farrer","year":"1985","unstructured":"Farrer LA, Yu PL (1985) Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease. Am J Med Genet 21(2):307\u2013316","journal-title":"Am J Med Genet"},{"key":"62_CR25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","volume":"20","author":"Trejo","year":"2004","unstructured":"Trejo A, Tarrats RM, Alonso ME, Boll MC, Ochoa A, Velasquez L (2004) Assessment of the nutrition status of patients with Huntington\u2019s disease. Nutrition 20(2):192\u2013196","journal-title":"Nutrition"},{"key":"62_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","volume":"47","author":"Pratley","year":"2000","unstructured":"Pratley RE, Salbe AD, Ravussin E, Caviness JN (2000) Higher sedentary energy expenditure in patients with Huntington\u2019s disease. Ann Neurol 47(1):64\u201370","journal-title":"Ann Neurol"},{"key":"62_CR27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1988.00520320068017","volume":"45","author":"Lanska","year":"1988","unstructured":"Lanska DJ, Lanska MJ, Lavine L, Schoenberg BS (1988) Conditions associated with Huntington\u2019s disease at death. A case-control study. Arch Neurol 45(8):878\u2013880","journal-title":"Arch Neurol"},{"key":"62_CR28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"Myers","year":"1991","unstructured":"Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK, et al. (1991) Factors associated with slow progression in Huntington\u2019s disease. Arch Neurol 48(8):800\u2013804","journal-title":"Arch Neurol"},{"key":"62_CR29","unstructured":"National Collaborating Centre for Acute Care (2006) Nutrition support in adults: Oral nutrition support, enteral tube feeding and parenteral nutrition. Report. London"},{"key":"62_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","volume":"443","author":"Morton","year":"2006","unstructured":"Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443(7109):289\u2013295","journal-title":"Nature"},{"key":"62_CR31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.physiol.70.120806.095256","volume":"70","author":"Sandoval","year":"2008","unstructured":"Sandoval D, Cota D, Seeley RJ (2008) The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu Rev Physiol 70:513\u2013535","journal-title":"Annu Rev Physiol"},{"key":"62_CR32","first-page":"307","volume":"66","author":"White","year":"2005","unstructured":"White HK (2005) Nutrition in advanced Alzheimer\u2019s disease. N C Med J 66(4):307\u2013312","journal-title":"N C Med J"},{"key":"62_CR33","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","volume":"15","author":"Raamsdonk Van","year":"2006","unstructured":"Van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, Leavitt BR, et al. (2006) Body weight is modulated by levels of full-length Huntingtin. Hum Mol Genet 15(9):1513\u20131523","journal-title":"Hum Mol Genet"},{"key":"62_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/pgmj.2005.037564","volume":"82","author":"Hickson","year":"2006","unstructured":"Hickson M (2006) Malnutrition and ageing. Postgrad Med J 82(963):2\u20138","journal-title":"Postgrad Med J"},{"key":"62_CR35","doi-asserted-by":"crossref","first-page":"M725","DOI":"10.1093\/gerona\/55.12.M725","volume":"55","author":"Thomas","year":"2000","unstructured":"Thomas DR, Ashmen W, Morley JE, Evans WJ (2000) Nutritional management in long-term care: development of a clinical guideline. Council for Nutritional Strategies in Long-Term Care. J Gerontol A Biol Sci Med Sci 55(12):M725\u2013M734","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"62_CR36","unstructured":"Malnutrition Universal Screening Tool. http:\/\/www.bapen.org.uk\/must_tool. html"},{"key":"62_CR37","unstructured":"Mini Nutritional Assessment. http:\/\/ www.nestle-nutrition.com\/tools\/mna. aspx"},{"key":"62_CR38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1079\/BJN20051622","volume":"95","author":"Stratton","year":"2006","unstructured":"Stratton RJ, King CL, Stroud MA, Jackson AA, Elia M (2006) \u2018Malnutrition Universal Screening Tool\u2019 predicts mortality and length of hospital stay in acutely ill elderly. Br J Nutr 95(2):325\u2013330","journal-title":"Br J Nutr"},{"key":"62_CR39","first-page":"466","volume":"10","author":"Guigoz","year":"2006","unstructured":"Guigoz Y (2006) The Mini Nutritional Assessment (MNA) review of the literature \u2013 What does it tell us? J Nutr Health Aging 10(6):466\u2013485","journal-title":"J Nutr Health Aging"},{"key":"62_CR40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clnu.2006.01.012","volume":"25","author":"Volkert","year":"2006","unstructured":"Volkert D, Berner YN, Berry E, Cederholm T, Coti BP, Milne A, et al. (2006) ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr 25(2): 330\u2013360","journal-title":"Clin Nutr"},{"key":"62_CR41","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/S0002-8223(97)00758-X","volume":"97","author":"Finley","year":"1997","unstructured":"Finley B (1997) Nutritional needs of the person with Alzheimer\u2019s disease: practical approaches to quality care. J Am Diet Assoc 97(10 Suppl 2):S177\u2013S180","journal-title":"J Am Diet Assoc"},{"key":"62_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-6712.1996.tb00304.x","volume":"10","author":"Ragneskog","year":"1996","unstructured":"Ragneskog H, Brane G, Karlsson I, Kihlgren M (1996) Influence of dinner music on food intake and symptoms common in dementia. Scand J Caring Sci 10(1):11\u201317","journal-title":"Scand J Caring Sci"},{"key":"62_CR43","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/bmj.38825.401181.7C","volume":"332","author":"Nijs","year":"2006","unstructured":"Nijs KA, de Graaf C, Kok FJ, van Staveren WA (2006) Effect of family style mealtimes on quality of life, physical performance, and body weight of nursing home residents: cluster randomised controlled trial. BMJ 332(7551):1180\u20131184","journal-title":"BMJ"},{"key":"62_CR44","doi-asserted-by":"crossref","first-page":"650S","DOI":"10.1093\/ajcn\/71.2.650s","volume":"71","author":"Poehlman","year":"2000","unstructured":"Poehlman ET, Dvorak RV (2000) Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr 71(2):650S\u2013655S","journal-title":"Am J Clin Nutr"},{"key":"62_CR45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/sj.mp.4001638","volume":"10","author":"Kishi","year":"2005","unstructured":"Kishi T, Elmquist JK (2005) Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry 10(2):132\u2013146","journal-title":"Mol Psychiatry"},{"key":"62_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1532-5415.2001.49009.x","volume":"49","author":"Rigler","year":"2001","unstructured":"Rigler SK, Webb MJ, Redford L, Brown EF, Zhou J, Wallace D (2001) Weight outcomes among antidepressant users in nursing facilities. J Am Geriatr Soc 49(1):49\u201355","journal-title":"J Am Geriatr Soc"},{"key":"62_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10401230209147454","volume":"14","author":"Masand","year":"2002","unstructured":"Masand PS, Gupta S (2002) Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry 14(3):175\u2013182","journal-title":"Ann Clin Psychiatry"},{"key":"62_CR48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00019442-200508000-00012","volume":"13","author":"Deberdt","year":"2005","unstructured":"Deberdt WG, Dysken MW, Rappaport SA, Feldman PD, Young CA, Hay DP, et al. (2005) Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Am J Geriatr Psychiatry 13(8):722\u2013730","journal-title":"Am J Geriatr Psychiatry"},{"key":"62_CR49","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","volume":"355","author":"Schneider","year":"2006","unstructured":"Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. (2006) Effectiveness of atypical antipsychotic drugs in patients with Alzheimer\u2019s disease. N Engl J Med 355(15):1525\u20131538","journal-title":"N Engl J Med"},{"key":"62_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1525-8610(04)70061-4","volume":"5","author":"White","year":"2004","unstructured":"White HK, McConnell ES, Bales CW, Kuchibhatla M (2004) A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer\u2019s disease subjects. J Am Med Dir Assoc 5(2):89\u201397","journal-title":"J Am Med Dir Assoc"},{"key":"62_CR51","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/bmj.301.6763.1256","volume":"301","author":"Levi","year":"1990","unstructured":"Levi S, Cox M, Lugon M, Hodkinson M, Tomkins A (1990) Increased energy expenditure in Parkinson\u2019s disease. BMJ 301(6763):1256\u20131257","journal-title":"BMJ"},{"key":"62_CR52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/cs0830199","volume":"83","author":"Markus","year":"1992","unstructured":"Markus HS, Cox M, Tomkins AM (1992) Raised resting energy expenditure in Parkinson\u2019s disease and its relationship to muscle rigidity. Clin Sci (Lond) 83(2):199\u2013204","journal-title":"Clin Sci"},{"key":"62_CR53","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/brain\/awm113","volume":"130","author":"Montaurier","year":"2007","unstructured":"Montaurier C, Morio B, Bannier S, Derost P, Arnaud P, Brandolini-Bunlon M, et al. (2007) Mechanisms of body weight gain in patients with Parkinson\u2019s disease after subthalamic stimulation. Brain 130(Pt 7):1808\u20131818","journal-title":"Brain"},{"key":"62_CR54","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ajcn\/81.6.1335","volume":"81","author":"Gaba","year":"2005","unstructured":"Gaba AM, Zhang K, Marder K, Moskowitz CB, Werner P, Boozer CN (2005) Energy balance in early-stage Huntington disease. Am J Clin Nutr 81(6):1335\u20131341","journal-title":"Am J Clin Nutr"},{"key":"62_CR55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.48.1.88","volume":"48","author":"Toth","year":"1997","unstructured":"Toth MJ, Fishman PS, Poehlman ET (1997) Free-living daily energy expenditure in patients with Parkinson\u2019s disease. Neurology 48(1):88\u201391","journal-title":"Neurology"},{"key":"62_CR56","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","volume":"2","author":"Mochel","year":"2007","unstructured":"Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, Perin L, et al. (2007) Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS ONE 2(7):e647","journal-title":"PLoS ONE"},{"key":"62_CR57","first-page":"214","volume":"4","author":"Chouinard","year":"2000","unstructured":"Chouinard J (2000) Dysphagia in Alzheimer disease: a review. J Nutr Health Aging 4(4):214\u2013217","journal-title":"J Nutr Health Aging"},{"key":"62_CR58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","volume":"2","author":"Pfeiffer","year":"2003","unstructured":"Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 2(2):107\u2013116","journal-title":"Lancet Neurol"},{"key":"62_CR59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02493441","volume":"7","author":"Kagel","year":"1992","unstructured":"Kagel MC, Leopold NA (1992) Dysphagia in Huntington\u2019s disease: a 16-year retrospective. Dysphagia 7(2):106\u2013114","journal-title":"Dysphagia"},{"key":"62_CR60","first-page":"133","volume":"63","author":"Hawkes","year":"2006","unstructured":"Hawkes C (2006) Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol 63:133\u2013151","journal-title":"Adv Otorhinolaryngol"},{"key":"62_CR61","doi-asserted-by":"crossref","first-page":"M200","DOI":"10.1093\/gerona\/56.4.M200","volume":"56","author":"Mathey","year":"2001","unstructured":"Mathey MF, Siebelink E, de Graaf C, van Staveren WA (2001) Flavor enhancement of food improves dietary intake and nutritional status of elderly nursing home residents. J Gerontol A Biol Sci Med Sci 56(4):M200\u2013M205","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"62_CR62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","volume":"50","author":"Rogers","year":"1998","unstructured":"Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998) A 24- week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2019s disease. Donepezil Study Group. Neurology 50(1):136\u2013145","journal-title":"Neurology"},{"key":"62_CR63","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","volume":"318","author":"Rosler","year":"1999","unstructured":"Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal Bianco P, et al. (1999) Efficacy and safety of rivastigmine in patients with Alzheimer\u2019s disease: international randomised controlled trial. BMJ 318(7184):633\u2013638","journal-title":"BMJ"},{"key":"62_CR64","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","volume":"54","author":"Raskind","year":"2000","unstructured":"Raskind MA, Peskind ER, Wessel T, Yuan W (2000) Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology 54(12):2261\u20132268","journal-title":"Neurology"},{"key":"62_CR65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-510X(76)90253-7","volume":"30","author":"Vardi","year":"1976","unstructured":"Vardi J, Oberman Z, Rabey I, Streifler M, Ayalon D, Herzberg M (1976) Weight loss in patients treated longterm with levodopa. Metabolic aspects. J Neurol Sci 30(1):33\u201340","journal-title":"J Neurol Sci"},{"key":"62_CR66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0002-8223(95)00269-3","volume":"95","author":"Beyer","year":"1995","unstructured":"Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC (1995) Weight change and body composition in patients with Parkinson\u2019s disease. J Am Diet Assoc 95(9):979\u2013983","journal-title":"J Am Diet Assoc"},{"key":"62_CR67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0404.2004.00364.x","volume":"111","author":"Palhagen","year":"2005","unstructured":"Palhagen S, Lorefalt B, Carlsson M, Ganowiak W, Toss G, Unosson M, et al. (2005) Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson\u2019s disease? Acta Neurol Scand 111(1):12\u201320","journal-title":"Acta Neurol Scand"},{"key":"62_CR68","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/mds.21086","volume":"21","author":"Kumru","year":"2006","unstructured":"Kumru H, Santamaria J, Valldeoriola F, Marti MJ, Tolosa E (2006) Increase in body weight after pramipexole treatment in Parkinson\u2019s disease. Mov Disord 21(11):1972\u20131974","journal-title":"Mov Disord"},{"key":"62_CR69","doi-asserted-by":"crossref","unstructured":"Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66(3):366\u2013372","DOI":"10.1212\/01.wnl.0000198586.85250.13"},{"key":"62_CR70","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/01.WNL.0000160388.96242.77","volume":"64","author":"Tabrizi","year":"2005","unstructured":"Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AH, et al. (2005) High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study. Neurology 64(9):1655\u20131656","journal-title":"Neurology"},{"key":"62_CR71","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1007\/s100720200066","volume":"23","author":"Arabia","year":"2002","unstructured":"Arabia G, Zappia M, Bosco D, Crescibene L, Bagala A, Bastone L, et al. (2002) Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson\u2019s disease. Neurol Sci 23(Suppl 2):S53\u2013S54","journal-title":"Neurol Sci"},{"key":"62_CR72","first-page":"304","volume":"7","author":"Gil","year":"2003","unstructured":"Gil GP, Ramirez Diaz SP, Ribera Casado JM (2003) Dementia and Nutrition. Intervention study in institutionalized patients with Alzheimer disease. J Nutr Health Aging 7(5):304\u2013308","journal-title":"J Nutr Health Aging"},{"key":"62_CR73","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1532-5415.2004.52464.x","volume":"52","author":"Lauque","year":"2004","unstructured":"Lauque S, Arnaud-Battandier F, Gillette S, Plaze JM, Andrieu S, Cantet C, et al. (2004) Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer\u2019s disease at risk of malnutrition: a prospective randomized study. J Am Geriatr Soc 52(10):1702\u20131707","journal-title":"J Am Geriatr Soc"},{"key":"62_CR74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.clnu.2004.12.006","volume":"24","author":"Salas-Salvado","year":"2005","unstructured":"Salas-Salvado J, Torres M, Planas M, Altimir S, Pagan C, Gonzalez ME, et al. (2005) Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer\u2019s disease. Clin Nutr 24(3):390\u2013397","journal-title":"Clin Nutr"},{"key":"62_CR75","unstructured":"World Health Organisation (2004) Human energy requirements: Report of a joint FAO\/WHO\/UNU expert consultation. FAO FOOD AND NUTRITION TECHNICAL REPORT SERIES 1. Report. Rome"},{"key":"62_CR76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clnu.2006.08.003","volume":"26","author":"Gaillard","year":"2007","unstructured":"Gaillard C, Alix E, Salle A, Berrut G, Ritz P (2007) Energy requirements in frail elderly people: a review of the literature. Clin Nutr 26(1):16\u201324","journal-title":"Clin Nutr"},{"key":"62_CR77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ageing\/28.5.469","volume":"28","author":"Groot de","year":"1999","unstructured":"de Groot CP, van den BT, van Staveren W (1999) Energy intake and micronutrient intake in elderly Europeans: seeking the minimum requirement in the SENECA study. Age Ageing 28(5):469\u2013474","journal-title":"Age Ageing"},{"key":"62_CR78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.2007.18.3-4.223","volume":"18","author":"Aziz","year":"2007","unstructured":"Aziz NA, Swaab DF, Pijl H, Roos RA (2007) Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington\u2019s disease: clinical consequences and therapeutic implications. Rev Neurosci 18(3\u20134):223\u2013251","journal-title":"Rev Neurosci"},{"key":"62_CR79","unstructured":"Swaab DF (2004) The human hypothalamus: basic and clinical aspects, part II: neuropathology of the human hypothalamus and adjacent structures. Amsterdam, The Netherlands: Elsevier"},{"key":"62_CR80","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"Thannickal","year":"2007","unstructured":"Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson\u2019s disease. Brain 130(Pt 6):1586\u20131595","journal-title":"Brain"},{"key":"62_CR81","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","volume":"130","author":"Fronczek","year":"2007","unstructured":"Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, Van Duinen SG, et al. (2007) Hypocretin (orexin) loss in Parkinson\u2019s disease. Brain 130(Pt 6):1577\u20131585","journal-title":"Brain"},{"key":"62_CR82","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1097\/00001756-200011270-00019","volume":"11","author":"Kunig","year":"2000","unstructured":"Kunig G, Leenders KL, Martin-Solch C, Missimer J, Magyar S, Schultz W (2000) Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 11(17):3681\u20133687","journal-title":"Neuroreport"},{"key":"62_CR83","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.46.6.1585","volume":"46","author":"Grundman","year":"1996","unstructured":"Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ (1996) Low body weight in Alzheimer\u2019s disease is associated with mesial temporal cortex atrophy. Neurology 46(6):1585\u20131591","journal-title":"Neurology"},{"key":"62_CR84","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","volume":"18","author":"Aziz","year":"2008","unstructured":"Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, et al. (2008) Hypocretin and melaninconcentrating hormone in patients with Huntington disease. Brain Pathol 18(4):474\u2013483","journal-title":"Brain Pathol"},{"key":"62_CR85","first-page":"122","volume":"8","author":"Rypkema","year":"2004","unstructured":"Rypkema G, Adang E, Dicke H, Naber T, de Swart B, Disselhorst L, et al. (2004) Cost-effectiveness of an interdisciplinary intervention in geriatric inpatients to prevent malnutrition. J Nutr Health Aging 8(2):122\u2013127","journal-title":"J Nutr Health Aging"},{"key":"62_CR86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.2003.017822","volume":"75","author":"Hamilton","year":"2004","unstructured":"Hamilton JM, Wolfson T, Peavy GM, Jacobson MW, Corey-Bloom J (2004) Rate and correlates of weight change in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 75(2):209\u2013212","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"62_CR87","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000074445","volume":"78","author":"Gonzalez","year":"2003","unstructured":"Gonzalez De Aguilar JL, Rene F, Dupuis L, Loeffler JP (2003) Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models. Neuroendocrinology 78(5):244\u2013252","journal-title":"Neuroendocrinology"},{"key":"62_CR88","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, et al. (2007) Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6(7):2833\u20132840","journal-title":"J Proteome Res"},{"key":"62_CR89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1523-5378.2005.00331.x","volume":"10","author":"Dobbs","year":"2005","unstructured":"Dobbs RJ, Dobbs SM, Weller C, Bjarnason IT, Oxlade NL, Charlett A, et al. (2005) Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism. Helicobacter 10(4):267\u2013275","journal-title":"Helicobacter"},{"key":"62_CR90","first-page":"281","volume":"4","author":"Mahieux","year":"2006","unstructured":"Mahieux F, Couderc R, Fenelon G, Maachi M (2006) Relationships between weight loss and circulating cytokines in patients with Alzheimer\u2019s disease. Psychol Neuropsychiatr Vieil 4(4):281\u2013286","journal-title":"Psychol Neuropsychiatr Vieil"},{"key":"62_CR91","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0197-4580(97)80309-0","volume":"18","author":"Hartmann","year":"1997","unstructured":"Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I, Stypula G, et al. (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer\u2019s and Parkinson\u2019s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 18(3):285\u2013289","journal-title":"Neurobiol Aging"},{"key":"62_CR92","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/01.WNL.0000106840.72938.84","volume":"62","author":"Okun","year":"2004","unstructured":"Okun MS, DeLong MR, Hanfelt J, Gearing M, Levey A (2004) Plasma testosterone levels in Alzheimer and Parkinson diseases. Neurology 62(3):411\u2013413","journal-title":"Neurology"},{"key":"62_CR93","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","volume":"57","author":"Markianos","year":"2005","unstructured":"Markianos M, Panas M, Kalfakis N, Vassilopoulos D (2005) Plasma testosterone in male patients with Huntington\u2019s disease: relations to severity of illness and dementia. Ann Neurol 57(4):520\u2013525","journal-title":"Ann Neurol"},{"key":"62_CR94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","volume":"10","author":"Fain","year":"2001","unstructured":"Fain JN, Del Mar NA, Meade CA, Reiner A, Goldowitz D (2001) Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington\u2019s disease mutation. Hum Mol Genet 10(2):145\u2013152","journal-title":"Hum Mol Genet"},{"key":"62_CR95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","volume":"48","author":"Lodi","year":"2000","unstructured":"Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, et al. (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington\u2019s disease and dentatorubropallidoluysian atrophy. Ann Neurol 48(1):72\u201376","journal-title":"Ann Neurol"},{"key":"62_CR96","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","volume":"20","author":"Saft","year":"2005","unstructured":"Saft C, Zange J, Andrich J, Muller K, Lindenberg K, Landwehrmeyer B, et al. (2005) Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington\u2019s disease. Mov Disord 20(6):674\u2013679","journal-title":"Mov Disord"},{"key":"62_CR97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.56.5.655","volume":"56","author":"Vanhanen","year":"2001","unstructured":"Vanhanen M, Kivipelto M, Koivisto K, Kuusisto J, Mykkanen L, Helkala EL, et al. (2001) APOE-epsilon4 is associated with weight loss in women with AD: a population-based study. Neurology 56(5):655\u2013659","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-0062-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-0062-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T10:11:20Z","timestamp":1709979080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-0062-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-0062-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}